A new strategy for the green synthesis of chondroitin sulfate-reduced gold nanoparticles; in vitro evaluation of synthesized nanoparticles

Maryam Asariha ^1,2 , Azam Chahrdoli ^2,3, Farshad Qalekhani ², Mahnaz Ghowsi ², Mehdi Fouladi ², Maryam Gholamhosseinpour ², Ali Fattahi ³ *

Cited by CrossRef: 5

1- Zhuang W, Shi C, Wang J, Su T, Lin T, Lin C, Wu X, Gao M, Chen H, Su Q. Preparation and properties of carboxylated styrene‐butadiene rubber/flue gas desulfurization ash composites by in situ carboxylate reaction. J of Applied Polymer Sci. 2022;139(31) [Crossref]

2- Aly S, El-Kamel A, Sheta E, El-Habashy S. Chondroitin/Lactoferrin-dual functionalized pterostilbene-solid lipid nanoparticles as targeted breast cancer therapy. International Journal of Pharmaceutics. 2023;642:123163 [Crossref]

3- Liu H, Zhang M, Meng F, Su C, Li J. Polysaccharide-based gold nanomaterials: Synthesis mechanism, polysaccharide structure-effect, and anticancer activity. Carbohydrate Polymers. 2023;321:121284 [Crossref]

4- Marchi R, Campos I, Santana V, Carlos R. Chemical implications and considerations on techniques used to assess the in vitro antioxidant activity of coordination compounds. Coordination Chemistry Reviews. 2022;451:214275 [Crossref]

5- Asariha M, Kiaie S, Izadi S, H. Pirhayati F, Fouladi M, Gholamhosseinpour M. Extended-release of doxorubicin through green surface modification of gold nanoparticles: in vitro and in ovo assessment. BMC Chemistry. 2022;16(1) [Crossref]

6- Dastgir M, Ayyami Y, Pourfarshid A, Ghorbani M, Mortezazadeh T. Evaluation of the theranostic characteristics of chitosan-decorated bismuth oxide nanoparticles conjugated curcumin and 5-aminolevulinic acid as a biocompatible targeted nanoplatform in CT and breast cancer radiation therapy. Journal of Drug Delivery Science and Technology. 2024;92:105279 [Crossref]

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics Policies Editorial Board Policy Abstracting and Indexing Archive

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences.
Acceptance rate: 24%
Publication fee: Free of charge

Indexing/Abstracting Info
PubMed; PubMed Central; Scopus; Science Citation Index Expanded, Google Scholar; SJR ; Essential Science Indicators; Publons; Embase; EBSCOhost; CAS: DOAJ: SHERPA/RoMEO; Ulrich
Member of COPE
Follower of ICMJE
Permission: Creative Commons